Fresenius Kabi wins FDA approval for Stelara biosimilar Otulfi
Otulfi is the fourth Stelara biosimilar approved in the US but will not launch until early 2025.
Otulfi is the fourth Stelara biosimilar approved in the US but will not launch until early 2025.
What's Your Reaction?
